GURU.Markets stock price, segment price, and overall market index valuation
The company's share price KORU Medical Systems
KORU Medical produces portable infusion systems for subcutaneous drug administration. Its stock price reflects the growing home therapy market. The chart tells the story of the transition of treatment for many chronic conditions from hospitals to the home.
Share prices of companies in the market segment - Medical instruments
KORU Medical Systems develops and manufactures portable infusion systems for subcutaneous drug administration at home. We've categorized it under "Medical Instruments." The chart below shows how the market values ββcompanies that make treatment more convenient for patients.
Broad Market Index - GURU.Markets
KORU Medical Systems develops and manufactures portable infusion systems for subcutaneous drug administration at home. As a component of the GURU.Markets index, it represents the home medicine sector. The chart below represents the entire market. See how this company's stock compares to the overall trend.
Change in the price of a company, segment, and market as a whole per day
KRMD - Daily change in the company's share price KORU Medical Systems
Shares of KORU, a manufacturer of infusion systems, reflect stability in the medical technology sector. change_co measures sensitivity to demand from immunocompromised patients. This metric is important for analyzing niche medical companies with stable businesses on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Medical instruments
KORU Medical Systems, Inc. is a company in the medical device sector. This chart illustrates the high volatility of the MedTech industry. Comparing this to KRMD, which focuses on infusion systems, helps us understand how its innovative products contribute to its volatility.
Daily change in the price of a broad market stock, index - GURU.Markets
KORU Medical Systems produces systems for subcutaneous drug administration at home. Its business is growing thanks to the trend toward decentralized medical care. The company's stock price reflects these important changes in healthcare and is part of a broader, multifaceted picture of market volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization KORU Medical Systems
KORU Medical Systems' year-over-year performance is a story of growth in the home subcutaneous infusion market. Its 12-month market capitalization growth reflects the growing number of immunocompromised patients using its infusion systems for self-administration of medications, offering a more convenient and cost-effective alternative to hospital-based intravenous procedures.
Annual dynamics of market capitalization of the market segment - Medical instruments
KORU Medical Systems is a manufacturer of infusion systems for subcutaneous drug administration at home. Its technology improves patients' quality of life. The chart shows how its leadership in this niche and the trend toward home-based treatments are driving its growth ahead of the rest of the medical equipment sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
KORU, with its subcutaneous infusion system, operates in the defense sector. Demand for its medical equipment is driven not by economics, but by patient needs. The company's stock price reflects stable, non-cyclical growth driven by continued demand for its unique technology.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization KORU Medical Systems
The growth of KORU, a medical device manufacturer, depends on the adoption of its technology. The monthly fluctuations on the chart reflect the growth in sales of its infusion systems for subcutaneous administration of drugs used in immunocompromised patients.
Monthly dynamics of market capitalization of the market segment - Medical instruments
KORU Medical Systems produces infusion systems for subcutaneous drug administration at home. The home-use medical device sector is growing thanks to the trend toward decentralized care. The industry dynamics chart demonstrates the level of confidence among investors and the healthcare system in this model, which improves patient convenience and reduces costs.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
KORU Medical Systems develops and manufactures medical devices for subcutaneous drug administration at home. Its business is growing alongside the trend of shifting treatment from hospitals to the home. A broader market analysis chart shows how much demand its niche technology, which improves convenience for patients with chronic conditions, has generated, regardless of the general sentiment.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization KORU Medical Systems
KORU Medical Systems produces infusion systems for subcutaneous drug administration at home. Its weekly stock price is driven by the growth of the home therapy market, partnerships with pharmaceutical companies, and competition in the medical device market.
Weekly dynamics of market capitalization of the market segment - Medical instruments
KORU Medical Systems produces infusion systems for subcutaneous medication administration at home. This allows patients to avoid frequent hospital visits. Is the company growing faster than the industry due to the trend toward home treatment? The chart below shows how the market views its prospects compared to other medical equipment manufacturers.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
KORU Medical produces medical equipment for home infusions. Demand for its products is less dependent on economic cycles, making the sector "defensive." The chart will show whether the company's shares are indeed less volatile than the market, ensuring stability.
Market capitalization of the company, segment and market as a whole
KRMD - Market capitalization of the company KORU Medical Systems
KORU Medical Systems' market capitalization chart reflects its niche position in the market for subcutaneous infusion systems for home medication administration. Its market valuation demonstrates investors' belief in the trend of shifting treatment from hospitals to the home, making its systems increasingly popular among patients with chronic conditions.
KRMD - Share of the company's market capitalization KORU Medical Systems within the market segment - Medical instruments
KORU Medical Systems is a leader in the development and production of portable infusion systems for subcutaneous drug administration at home. Its dominant market share in this niche reflects its technology. The chart shows the company's importance in providing patients with chronic diseases with greater freedom and independence.
Market capitalization of the market segment - Medical instruments
Here's a chart showing the market capitalization of the medical equipment sector. KORU Medical Systems is a niche leader in subcutaneous infusion systems for home use. The growth of this market reflects the trend of shifting treatment from the hospital to the home. KORU offers patients with immunodeficiencies a convenient and effective treatment solution.
Market capitalization of all companies included in a broad market index - GURU.Markets
KORU Medical produces infusion systems for subcutaneous drug administration at home. Its market capitalization reflects the trend of shifting therapy from the hospital to the home. The chart below shows the economic weight of companies making treatment more convenient for patients.
Book value capitalization of the company, segment and market as a whole
KRMD - Book value capitalization of the company KORU Medical Systems
KORU Medical's foundation is its manufacturing capabilities for creating infusion systems for subcutaneous drug administration at home. The chart shows how this specialized medical company is expanding its assets to meet the growing demand for home therapy, which is more convenient and affordable for patients.
KRMD - Share of the company's book capitalization KORU Medical Systems within the market segment - Medical instruments
KORU Medical Systems produces subcutaneous infusion systems. The chart shows its share of real assets. These are its manufacturing facilities, where pumps and consumables are assembled, allowing patients to receive treatment at home.
Market segment balance sheet capitalization - Medical instruments
KORU Medical manufactures infusion systems at its own plant. This business requires investment in production lines, making it capital-intensive. The chart below shows the total asset value of the medical equipment sector, providing a backdrop for assessing its base.
Book value of all companies included in the broad market index - GURU.Markets
KORU Medical Systems produces systems for subcutaneous drug administration at home. The company's assets are its production facilities. Its stake in BCap_All represents its physical scale in providing patients with devices that give them freedom and independence from hospital procedures.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - KORU Medical Systems
KORU Medical is a manufacturer of infusion systems for subcutaneous drug administration. Its value stems from its niche technology, which allows patients to administer infusions at home, and its growth potential in the biologics market.
Market to book capitalization ratio in a market segment - Medical instruments
KORU Medical Systems produces portable infusion systems for subcutaneous drug administration. This figure reflects the market premium for its specialized devices and their role in home-based chronic disease treatment, over and above the value of its manufacturing assets.
Market to book capitalization ratio for the market as a whole
KORU Medical Systems produces portable infusion systems for subcutaneous drug administration at home. This allows patients to be more mobile. This chart helps assess the market premium for medical technologies that improve quality of life, over and above the value of the company's tangible assets.
Debts of the company, segment and market as a whole
KRMD - Company debts KORU Medical Systems
KORU Medical Systems, a manufacturer of portable subcutaneous infusion systems, is using the capital to expand its market presence. The leveraged strategy is aimed at increasing production capacity, expanding its sales team to serve clinical clients, and conducting research to adapt its systems to new medications.
Market segment debts - Medical instruments
KORU Medical Systems produces infusion systems for subcutaneous medication administration at home. This enables the treatment of chronic diseases outside of the hospital. This chart shows how the company is funding the production of its medical devices and expanding its presence in the growing home therapy market, which is becoming increasingly popular.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio KORU Medical Systems
KORU Medical Systems manufactures infusion systems for subcutaneous drug administration. Expanding production and entering new markets requires investment. This chart shows the extent to which the company uses debt to finance its growth. It helps assess the financial flexibility and risks associated with its business scaling strategy.
Market segment debt to market segment book capitalization - Medical instruments
KORU Medical Systems produces portable infusion systems for subcutaneous drug administration at home. This chart shows debt trends in the medical devices sector. It helps assess how the company is financing the growing demand for its products, which allow patients to receive treatment outside the hospital, and how its financial strategy compares to its competitors.
Debt to book value of all companies in the market
KORU Medical Systems produces specialized infusion systems for subcutaneous drug administration. Growth in the medical device sector can be financed both through profits and through debt for production expansion or entry into new markets. This total debt load chart provides an indication of how conservatively or aggressively KORU manages its balance sheet compared to the market as a whole.
P/E of the company, segment and market as a whole
P/E - KORU Medical Systems
KORU Medical Systems produces specialized infusion systems for subcutaneous drug administration at home. This chart shows the market valuation of the company, which is benefiting from the home treatment trend. This valuation depends on the growing number of patients using its system and the expanding list of compatible medications.
P/E of the market segment - Medical instruments
This chart reflects the average rating for medical instrument manufacturers, providing context for KORU Medical. It demonstrates general expectations for the sector. Comparisons with this chart help us understand whether KORU's niche business of home infusion systems is considered more or less promising than that of major medical equipment manufacturers.
P/E of the market as a whole
KORU Medical Systems produces portable infusion systems for subcutaneous drug administration at home. The company is benefiting from the trend of shifting treatments from hospitals to homes. This chart of overall sentiment in the medtech sector helps understand how investors view this long-term trend and KORU Medical Systems' ability to capitalize on it.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company KORU Medical Systems
KORU Medical Systems manufactures and markets subcutaneous drug delivery systems that allow patients to administer infusions at home. This graph shows the expected growth of the home therapy market. This estimate depends on the growing number of drugs approved for subcutaneous administration and patient preference for treatment in the comfort of their own home.
Future (projected) P/E of the market segment - Medical instruments
KORU Medical Systems develops, manufactures, and markets portable medical devices for subcutaneous drug administration at home. This chart shows the company's estimated future revenue in the context of the medical equipment sector. It demonstrates investor confidence in the growth of the home infusion therapy market and KORU's position within it.
Future (projected) P/E of the market as a whole
KORU Medical Systems produces infusion systems for subcutaneous drug administration at home. This overall market sentiment trend is less important for KRMD than the trend toward shifting treatment from hospitals to homes. Demand for their products is driven by the growing number of patients with chronic conditions requiring regular infusions, making their business non-cyclical.
Profit of the company, segment and market as a whole
Company profit KORU Medical Systems
KORU Medical Systems produces infusion systems for subcutaneous drug administration, allowing patients to administer therapy at home. This chart shows the financial results of the business, which is benefiting from the trend of shifting treatment from hospitals to the home.
Profit of companies in the market segment - Medical instruments
KORU Medical Systems produces infusion systems for subcutaneous drug administration at home. This chart shows the profitability of the medical equipment sector. For KRMD, this reflects the trend of shifting treatment from hospitals to homes. Their systems allow patients with chronic diseases to receive therapy in a comfortable environment.
Overall market profit
KORU Medical Systems produces specialized infusion systems for subcutaneous drug administration at home. This allows patients with chronic diseases to receive therapy without visiting a hospital. The company's growth depends on the expansion of home treatment. This overall profitability chart is not affected by specific trends in the medical technology sector.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company KORU Medical Systems
KORU Medical Systems manufactures infusion systems for subcutaneous immunoglobulin administration at home. The revenue forecast presented here reflects expectations for growth in the home therapy market for chronic diseases. The shift of treatment from hospitals to home settings is a strong long-term trend supporting the company's business.
Future (predicted) profit of companies in the market segment - Medical instruments
KORU Medical Systems manufactures infusion systems for subcutaneous drug administration at home. The profit forecast for this sector depends on the growth of the market for biologics requiring this method of administration. This chart reflects analysts' expectations regarding the shift from intravenous infusions in hospitals to more convenient home procedures.
Future (predicted) profit of the market as a whole
KORU Medical Systems produces portable infusion systems for subcutaneous drug administration at home. Demand for its products is growing with the shift to home care. Market profit projections, presented here, impact healthcare budgets, which determine reimbursement for these devices.
P/S of the company, segment and market as a whole
P/S - KORU Medical Systems
KORU Medical Systems produces infusion systems for subcutaneous drug administration at home. This chart shows how the market evaluates its revenue. The growing trend of shifting treatment from hospitals to home settings is creating strong demand for its products, especially for patients with chronic immune diseases.
P/S market segment - Medical instruments
KORU Medical Systems develops and manufactures medical devices for subcutaneous drug administration at home, improving convenience for patients with chronic conditions. This chart shows the average revenue estimate for the sector, helping to understand how the market views KORU's technology and its role in the trend toward decentralized healthcare.
P/S of the market as a whole
KORU Medical Systems manufactures and markets portable subcutaneous drug delivery systems, allowing patients to administer infusions at home. The company's growth depends on the adoption of its technology. This chart provides a market-wide perspective for assessing investor sentiment regarding revenue prospects in the innovative home medical device sector.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company KORU Medical Systems
KORU Medical Systems develops and manufactures medical devices for subcutaneous drug administration at home. This chart shows how investors estimate the company's future sales. It reflects the trend of shifting treatment from hospitals to the home, which is convenient for patients with chronic diseases.
Future (projected) P/S of the market segment - Medical instruments
KORU Medical Systems produces infusion systems for subcutaneous drug administration, allowing patients to manage their treatments at home. This represents an important niche in healthcare. This chart reflects how the market perceives its technology, which improves patients' quality of life, and its growth potential in the home therapy segment.
Future (projected) P/S of the market as a whole
KORU Medical Systems manufactures and markets portable subcutaneous drug delivery systems, allowing patients to administer infusions at home. Their growth depends on the adoption of their technology. This graph, reflecting the stability of the healthcare system, is important. Economic growth provides funding for medical services, allowing patients and clinics to transition to more convenient treatment methods.
Sales of the company, segment and market as a whole
Company sales KORU Medical Systems
KORU Medical Systems produces infusion systems that allow patients with immunodeficiency and other chronic diseases to administer medications subcutaneously at home. This chart reflects sales of its medical devices. Revenue growth is driven by the growing trend of shifting treatment from hospitals to the more comfortable environment of home.
Sales of companies in the market segment - Medical instruments
KORU Medical Systems produces the FREEDOM infusion system, which allows patients to self-administer subcutaneous medications at home. This increases convenience and reduces healthcare costs. Their revenue structure is divided between sales of the pumps themselves and, more importantly, regular sales of disposable consumables for them.
Overall market sales
KORU Medical Systems develops and manufactures medical devices for subcutaneous drug administration, allowing patients to administer infusions at home. This increases convenience and reduces treatment costs. This revenue chart includes the healthcare sector, where KRMD facilitates the transition to home-based treatment, improving patients' quality of life.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company KORU Medical Systems
KORU Medical Systems produces specialized infusion systems for subcutaneous medication administration at home. This allows patients with chronic diseases to avoid frequent hospital visits. This chart shows analysts' expectations for growth in the home infusion therapy market, a key area for KORU.
Future (projected) sales of companies in the market segment - Medical instruments
KORU Medical Systems manufactures and markets portable medical devices for subcutaneous drug administration, allowing patients to administer infusions at home. This chart shows market forecasts for home infusion systems. It reflects the growing trend of shifting treatment from hospitals to the home, which is more convenient for patients and less expensive for the healthcare system.
Future (projected) sales of the market as a whole
KORU Medical Systems, a manufacturer of subcutaneous drug delivery systems, sees this chart as a reflection of healthcare trends. Rising overall economic forecasts provide funding for the transition to home treatment. KORU systems allow immunocompromised patients to self-administer medications, reducing costs and improving quality of life.
Marginality of the company, segment and market as a whole
Company marginality KORU Medical Systems
KORU Medical Systems develops and manufactures medical devices for subcutaneous drug delivery. The company focuses on a niche market, and its profitability depends on the sales volume of its infusion systems. This chart shows how successfully KORU monetizes its specialized technology while managing production and sales costs.
Market segment marginality - Medical instruments
KORU Medical Systems produces infusion systems for subcutaneous drug administration at home. This indicator reflects the value of its products for patients with chronic diseases. This high result reflects the growing trend for home treatment and the convenience of its systems for both patients and physicians.
Market marginality as a whole
#VALUE!
Employees in the company, segment and market as a whole
Number of employees in the company KORU Medical Systems
KORU Medical Systems manufactures and markets specialized infusion systems for subcutaneous medication administration at home. This graphic shows the team creating devices that enable patients with chronic diseases to self-administer medications, avoiding frequent hospital visits and improving their quality of life.
Share of the company's employees KORU Medical Systems within the market segment - Medical instruments
KORU Medical Systems produces systems for subcutaneous immunoglobulin administration at home, allowing patients to avoid hospital visits. The production and support of these medical devices requires a team of engineers and clinical specialists. This chart demonstrates the company's significant role in improving patients' quality of life, reflecting its importance in this medical device niche.
Number of employees in the market segment - Medical instruments
KORU Medical Systems produces infusion systems that allow patients to self-administer subcutaneous medications at home. This graphic shows the team creating devices that give patients with chronic diseases more freedom and independence from hospitals, improving their quality of life and reducing the burden on the healthcare system.
Number of employees in the market as a whole
KORU Medical Systems develops and manufactures portable medical devices for subcutaneous drug administration. The overall health of the healthcare system, supported by a stable economy and labor market, as shown in this graph, is essential for their growth. Financial stability allows patients and clinics to choose more convenient and modern treatment methods, such as KORU systems.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company KORU Medical Systems (KRMD)
KORU Medical Systems manufactures infusion systems for subcutaneous drug administration at home. This chart illustrates the balance between technology and service. The capitalization per employee indicator reflects the cost of the patented device but also takes into account the personnel required for production, sales, and patient support.
Market capitalization per employee (in thousands of dollars) in the market segment - Medical instruments
KORU Medical Systems develops and manufactures portable infusion systems for subcutaneous drug administration. It is a niche medical equipment manufacturer where value is determined by the uniqueness of its product. This chart shows how the market values ββthe company's technology and market share per employee compared to other players in the sector.
Market capitalization per employee (in thousands of dollars) for the overall market
KORU Medical Systems manufactures and sells portable infusion systems for subcutaneous drug administration. In the medical equipment niche, this metric reflects the value of its specialized products. It demonstrates how the company creates value by offering patients a convenient way to self-administer medications at home.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company KORU Medical Systems (KRMD)
KORU Medical Systems (formerly Repro-Med) produces portable infusion pumps for subcutaneous administration of medications (such as immunoglobulin) at home. This chart shows the profitability of their niche medical device. They provide patients with the opportunity to receive treatment at home, which is in demand. Efficiency lies in the production and sales of this specialized pump.
Profit per employee (in thousands of dollars) in the market segment - Medical instruments
KORU Medical Systems (KRMD) produces specialized infusion systems that allow patients to administer medications (such as immunoglobulin) subcutaneously at home, rather than in the hospital. This chart represents an industry benchmark. In medtech, it reflects how effectively KORU manages the production and sales of devices that save the healthcare system money and improve patients' quality of life.
Profit per employee (in thousands of dollars) for the market as a whole
KORU Medical Systems (KRMD) manufactures systems for subcutaneous drug administration (infusion) at home. They fill a niche between a syringe and an IV. Their "razor and blade" model offers a pump (Freedom60) and, more importantly, disposable tubing and needle sets. This chart shows how successfully their sales team is growing their installed base of pumps, leading to increased profits from consumables.
Sales to employees of the company, segment and market as a whole
Sales per company employee KORU Medical Systems (KRMD)
KORU Medical Systems produces portable infusion systems for subcutaneous drug administration. This graph demonstrates its effectiveness in the home healthcare niche. High revenue per employee is a result of the patented system, which allows patients to self-administer infusions, reducing healthcare costs and improving quality of life.
Sales per employee in the market segment - Medical instruments
KORU Medical (KRMD) produces subcutaneous drug delivery systems (infusion pumps), allowing patients to treat themselves at home. It's a niche medtech company. This chart shows how productive their model (R&D, manufacturing, sales) is. It compares how their team generates revenue per employee compared to giants in the medical devices sector.
Sales per employee for the market as a whole
KORU Medical is a manufacturer of specialized infusion systems. Their devices allow patients (for example, those with immunodeficiencies) to administer medications subcutaneously at home, rather than in the hospital. It's a "razor and blades" model (pump and consumables). This graph shows how their team generates recurring revenue.
Short shares by company, segment and market as a whole
Shares shorted by company KORU Medical Systems (KRMD)
KORU Medical (KRMD) produces medical devices (Freedom infusion systems) for subcutaneous drug administration at home, primarily for the treatment of immunodeficiency. This chart shows bearish bets. The rise in shorts may reflect concerns about dependence on a few large clients (pharmaceutical companies) or competition from alternative drug delivery methods.
Shares shorted by market segment - Medical instruments
KORU Medical (KRMD) produces infusion systems (syringe pumps) for subcutaneous drug administration at home, particularly for immunotherapy. This chart illustrates the overall sentiment in the medical device sector. It shows how many investors anticipate a downturn or regulatory challenges in this entire niche.
Shares shorted by the overall market
KORU Medical Systems produces home infusion systems. It's a defensive, high-demand medical business. Demand for its products is driven by physician orders, not the economic cycle. This makes the company resilient to general market fears, as can be seen in this chart.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator KORU Medical Systems (KRMD)
KORU Medical Systems (KRMD) produces medical devices for subcutaneous drug administration at home. Their Freedom60 system is used to treat immunodeficiency and other rare diseases. This chart measures momentum. It shows "overbought" (above 70) due to rising patient numbers in home treatment, or "oversold" (below 30) due to competition concerns.
RSI 14 Market Segment - Medical instruments
KORU Medical (KRMD) produces infusion systems that allow patients to self-administer medications (such as immunoglobulin) at home, rather than in the hospital. This chart shows the collective sentiment in the Medical Instruments sector. It helps investors understand whether KRMD's performance reflects the trend toward "home treatment" or whether the entire industry is overheated or oversold.
RSI 14 for the overall market
KORU Medical (KRMD) supplies infusion systems for home use. This chart shows that its business is "defensive." Demand for its products (for immunodeficiency) is unaffected by euphoria or panic. During periods of market panic, investors seek safe havens in companies with completely non-cyclical demand.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast KRMD (KORU Medical Systems)
KORU Medical Systems produces the Freedom infusion system, which allows patients to self-administer medications (subcutaneously), primarily immunoglobulin, at home. This chart shows the average target price from analysts, reflecting their outlook on the growth of the home infusion therapy market.
The difference between the consensus estimate and the actual stock price KRMD (KORU Medical Systems)
KORU Medical (formerly Repro-Med) is a medical technology company that produces home infusion systems for medications. Their pumps and needles are used by immunocompromised patients to self-administer medications. This chart shows how analysts assess their dominance in this niche and the trend toward home treatment.
Analyst consensus forecast for stock prices by market segment - Medical instruments
KORU Medical (KRMD) is a manufacturer of infusion systems (pumps) that allow patients to receive complex treatments (such as immunoglobulin) at home rather than in the hospital. This chart shows general expectations for the medical instrument sector. It reflects whether experts believe in the "hospital at home" trend and the growth of home therapy.
Analysts' consensus forecast for the overall market share price
KORU Medical Systems (formerly Repro-Med) produces subcutaneous infusion systems for home medication administration, specifically immunoglobulin, for patients with chronic diseases. This chart shows the overall market sentiment. For KORU, which operates in the protective sector (patients require treatment), overall optimism is important, but their growth is more dependent on patients transitioning to home treatment.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index KORU Medical Systems
KORU Medical is freedom for patients. They produce specialized infusion systems (pumps and consumables) that allow patients (for example, those with immunodeficiencies) to receive their medications at home, rather than in the hospital. This chart is a summary indicator of their razor and blade products. It reflects their ability to sell razors (pumps) and their growing, high-margin revenue from blades (consumables).
AKIMA Market Segment Index - Medical instruments
KORU Medical Systems produces Freedom infusion systems (syringe pumps and kits), which allow patients to administer medications subcutaneously at home. This chart shows the average index for the medical instruments sector. It helps investors assess how KORU's technology, which improves patients' quality of life, compares to the industry average.
The AKIM Index for the overall market
KORU Medical is a manufacturer of subcutaneous systems for the administration of immunoglobulins and other medications at home. This chart, reflecting the market average, provides context. It helps assess how this niche MedTech player, benefiting from the trend toward out-of-hospital treatment, compares to overall macroeconomic trends.